Emergence Agitation
Conditions
Keywords
EA
Brief summary
Primary we will Compare the Efficacy between Dexmedetomidine and "Propofol-lidocaine" mixture in preventing the post operative emergence agitation following sevoflurane anasthesia in pediatric ophthalmic surgeries Secondary we will evaluate time of extubation, time of orientation, Hemodynamic variables, Visual analog scale ( VAS), facial expressions scale , Adverse events
Detailed description
Emergence agitation (EA) is a frequent and distressing complication in pediatric anesthesia, particularly following the use of volatile agents such as sevoflurane. It is characterized by restlessness, inconsolable crying, disorientation, and incongruent behavior during the early recovery period from general anesthesia (Dahmani S et al.,2014 ). Although EA is usually self-limited, it may cause harm to patients by leading to self-injury, disruption of surgical sites, removal of intravenous lines, or increased stress for caregivers and healthcare providers. The reported incidence of EA in children ranges between 10% and 80%, with higher prevalence observed in younger patients and in ophthalmic surgeries due to sensory deprivation and postoperative discomfort (Dahmani S et al.,2014 ). Sevoflurane remains the most widely used inhalational agent in pediatric anesthesia because of its rapid induction, low airway irritability, and favorable hemodynamic profile. However, it has been consistently associated with a higher risk of EA compared with other anesthetic techniques (Zhang Y et al., 2022) - (Liu J et al., 2022). Dexmedetomidine, a highly selective α2-adrenergic receptor agonist, has emerged as a promising agent due to its sedative, analgesic, and anxiolytic properties without significant respiratory depression (Zhang Y et al., 2022) - (Liu J et al., 2022). Several studies have demonstrated its efficacy in reducing the incidence and severity of EA when administered perioperatively (Zhang Y et al., 2022)- (Abdel-Ghaffar HS et al., 2019). On the other hand, propofol, a short-acting intravenous anesthetic with sedative and antiemetic properties, has also been investigated for EA prevention. When combined with lidocaine, propofol infusion provides not only smooth sedation and rapid recovery but also decreases pain associated with injection and potentially modulates airway reflexes and emergence agitation (Kim YH et al., 2014). Previous studies have shown that a single bolus dose of propofol at the end of surgery can reduce EA incidence in children undergoing ophthalmic surgery (Aouad MT t al., 2007). Meta-analyses further confirmed the beneficial role of propofol in reducing EA and improving recovery profiles (Liu J et al.,2022) -(Li Y et al.,2019). In ophthalmic surgeries for young children, smooth emergence from anesthesia is crucial, as agitation can compromise surgical outcomes, increase the risk of complications, and delay recovery (Kim YH et al., 2014)- (Aouad MT t al., 2007).
Interventions
Dexmedetomidine 0.3mcg /kg over diluted in 10 ml 0.9% Na cl over 10 min and 10 min before end of surgery
Propofol 2mg/kg plus lidocaine 1mg/kg over 10 min and 10 min before end of surgery.
receive placebo 10 ml 0.9% Nacl over 10 min and 10 min before end of surgery
Sponsors
Study design
Eligibility
Inclusion criteria
* patients aged 2-8 years . * ASA physical status I-II. * Scheduled for elective surgeries under general anesthesia with sevoflurane
Exclusion criteria
* History of psychiatric illness or cognitive impairment. * Known allergy to study drugs. * Severe cardiovascular, hepatic, or renal disease. * Chronic use of sedatives or opioids.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of emergence agitation | Assessed at 5, 10, 15, and 30 minutes after extubation in the post-anesthesia care unit (PACU) | Incidence of emergence agitation assessed using Aono's Four-Point Scale after extubation in pediatric patients undergoing ophthalmic surgery under sevoflurane anesthesia. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Time to extubation | From discontinuation of anesthesia until extubation, up to 30 minutes | The interval between discontinuation of anesthetic agents and successful extubation. |
| Time to orientation | During recovery period in PACU, up to 30 minutes postoperatively | The interval between discontinuation of anesthetic agents and recovery of adequate consciousness to follow simple commands. |
| Hemodynamic variables | From baseline until 30 minutes postoperatively | Assessment of heart rate during emergence and recovery period. |
| Postoperative pain score | During the first 4 postoperative hours | Assessment of postoperative pain using Wong-Baker FACES scale according to patient age. |
| Adverse events | During surgery and within the first 24 postoperative hours | Incidence of adverse events including bradycardia, hypotension, nausea, vomiting, respiratory depression, and postoperative nausea and vomiting. |